Search research articles
Contact Us
Filters
Showing results (141-150 of 508) with videos related to
Page
of 51
Sort By:
European Heart Journal
|
August 27, 2023
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry
Alexandre Gautier, Fabien Picard, Gregory Ducrocq, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking
Alexandre Gautier, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology
|
August 13, 2013
Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients
Jan-Christian Reil, Jean-Claude Tardif, Ian Ford, et al.
International Journal of Cardiology
|
July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry
Michal Tendera, Kim Fox, Roberto Ferrari, et al.
European Journal of Preventive Cardiology
|
January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes
Emmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
European Heart Journal
|
March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials
Kim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine
|
June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction
Victoria Hamill, Ian Ford, Kim Fox, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
Ian Ford, Michele Robertson, Nicola Greenlaw, et al.
Seminars in Arthritis and Rheumatism
|
February 25, 2014
Up-titration of allopurinol in patients with gout
Claudine G Jennings, Isla S Mackenzie, Rob Flynn, et al.
Journal of the American College of Cardiology
|
March 2, 2019
Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease
Fabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
Page
of 51
Search research articles
Search
Showing results (141-150 of 508) with videos related to
Sort By:
Page
of 51
European Heart Journal
|
August 27, 2023
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry
Alexandre Gautier, Fabien Picard, Gregory Ducrocq, et al.
European Journal of Preventive Cardiology
|
February 24, 2021
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking
Alexandre Gautier, Gregory Ducrocq, Yedid Elbez, et al.
Journal of the American College of Cardiology
|
August 13, 2013
Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients
Jan-Christian Reil, Jean-Claude Tardif, Ian Ford, et al.
International Journal of Cardiology
|
July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry
Michal Tendera, Kim Fox, Roberto Ferrari, et al.
European Journal of Preventive Cardiology
|
January 8, 2023
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes
Emmanuelle Vidal-Petiot, Yedid Elbez, Jules Mesnier, et al.
European Heart Journal
|
March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials
Kim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine
|
June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction
Victoria Hamill, Ian Ford, Kim Fox, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
Ian Ford, Michele Robertson, Nicola Greenlaw, et al.
Seminars in Arthritis and Rheumatism
|
February 25, 2014
Up-titration of allopurinol in patients with gout
Claudine G Jennings, Isla S Mackenzie, Rob Flynn, et al.
Journal of the American College of Cardiology
|
March 2, 2019
Generalizability of the REDUCE-IT Trial in Patients With Stable Coronary Artery Disease
Fabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
Page
of 51